cp wire

CP Wire Articles

Seattle Genetics Announces Results of Two Ph II Trials of Tucatinib in HER2- Positive Metastatic Breast Cancer
  • Tucatinib has been granted orphan drug status for the treatment of breast cancer patients with brain metastases.
  • Overall response rate (ORR) was 61% for Ph Ib triplet study
  • ... read more
Wed, 07/11/18 - 09:37 am
Microbiome Report for the week ending 7-7-18

Nextbiotix raises $8 Million in Series A round
Tue, 07/10/18 - 04:53 pm
FTC Clears Takeda's Acquisition of Shire

Takeda Pharmaceutical Company Limited (“Takeda”) announce on 7/10/18 that it has received unconditional clearance from the United States Federal Trade Commission (“FTC”) for the proposed... read more

Tue, 07/10/18 - 09:49 am
Boehringer Ingelheim Invests More Than $230 Million in Veterinary Public Health Production Center in Europe's “Vaccine Valley”
  • New site will enable the company to respond to the growing global demand for foot-and-mouth disease and Bluetongue virus control
  • It represents a record investment into the company’s... read more
Tue, 07/10/18 - 09:42 am
Tetra Discovery Partners Initiates Ph II Trial of Fragile X Syndrome Drug
  • BPN14770 has received orphan drug designation
  • Also in trials for Alzheimer's and traumatic brain injury
  • Ph I trials showed excellent safety and improved cognitive capability... read more
Tue, 07/10/18 - 09:27 am

Pages